Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Toxicology

• Publication date

  2013-09-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.tox.2013.07.004PMID 23856525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substituted N-Benzylpyrazine-2-carboxamides: Synthesis and Biological Evaluation †

  2012cited by this paper
• Tenofovir Renal Proximal Tubular Toxicity Is Regulated By OAT1 and MRP4 Transporters

  2011cited by this paper
• Drug uptake transporters in antiretroviral therapy.

  2011cited by this paper
• Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).

  2011cited by this paper
• The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.

  2011cited by this paper
• The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.

  2010cited by this paper
• The Human Concentrative Nucleoside Transporter-3 C602R Variant Shows Impaired Sorting to Lipid Rafts and Altered Specificity for Nucleoside-Derived Drugs

  2010cited by this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010cited by this paper
• Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.

  2009cited by this paper
• ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer

  2009cited by this paper
• GS-9191 Is a Novel Topical Prodrug of the Nucleotide Analog 9-(2-Phosphonylmethoxyethyl)Guanine with Antiproliferative Activity and Possible Utility in the Treatment of Human Papillomavirus Lesions

  2009cited by this paper
• GS-9219—A Novel Acyclic Nucleotide Analogue with Potent Antineoplastic Activity in Dogs with Spontaneous Non–Hodgkin's Lymphoma

  2008cited by this paper
• Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and Accumulation

  2008cited by this paper
• MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells

  2008cited by this paper
• Genistein protects the kidney from cisplatin-induced injury.

  2008cited by this paper
• ABC multidrug transporters: structure, function and role in chemoresistance.

  2008cited by this paper
• The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).

  2008cited by this paper
• Emerging antiviral drugs

  2008cited by this paper
• The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.

  2007cited by this paper
• Renal Transport of Adefovir, Cidofovir, and Tenofovir by SLC22A Family Members (hOAT1, hOAT3, and hOCT2)

  2007cited by this paper
• Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles

  2007cited by this paper
• The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.

  2007cited by this paper
• Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.

  2007cited by this paper
• Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.

  2006cited by this paper
• Antiviral acyclic nucleoside phosphonates structure activity studies.

  2006cited by this paper
• Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.

  2006cited by this paper
• Structure-affinity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolites.

  2005cited by this paper
• Antiviral drug-induced nephrotoxicity.

  2005cited by this paper
• Organic anion transporter (Slc22a) family members as mediators of toxicity.

  2005cited by this paper
• Transport of organic anions across the basolateral membrane of proximal tubule cells.

  2003cited by this paper
• Synthesis and cytostatic activity of n-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, 2,6-diaminopurines and related compounds

  2001cited by this paper
• Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.

  2000cited by this paper
• The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1.

  1999cited by this paper
• Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base.

  1999cited by this paper
• 9-(2-phosphonylmethoxyethyl) derivatives of purine nucleotide analogs: A comparison of their metabolism and interaction with cellular DNA synthesis.

  1999cited by this paper
• Disposition of the Acyclic Nucleoside Phosphonate (S)-9(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine

  1998cited by this paper
• Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication.

  1997cited by this paper
• Renal Transporters for Organic Anions and Organic Cations. Structural Requirements for Substrates

  1997cited by this paper
• Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.

  1996cited by this paper
• Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.

  1991cited by this paper

• Studies on the interaction of five triazole fungicides with human renal transporters in cells.

  2023cites this paper
• Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes

  2022cites this paper
• Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication

  2022cites this paper
• Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine

  2021cites this paper
• Transit and Metabolic Pathways of Quercetin in Tubular Cells: Involvement of Its Antioxidant Properties in the Kidney

  2021cites this paper
• Tenofovir and Renal Toxicity at Cellular Level

  2017cites this paper
• Single-cell resolution of intracellular T cell Ca2+ dynamics in response to frequency-based H2O2 stimulation.

  2017cites this paper
• Renal Drug Transporters and Drug Interactions

  2017cites this paper
• A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity

  2016cites this paper
• The pregnane X receptor down‐regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for (“squelching”) SRC‐1 coactivator

  2016cites this paper
• Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug–Drug Interactions

  2016influential citation
• Development of in-vitro human and rat proximal tubule cell models as a platform for drug transporter and drug-drug interaction studies

  2015influential citation
• Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC/TERT1.

  2015cites this paper
• The renal handling of amphotericin B and amphotericin B / deoxycholate and potential 1 renal drug-drug interactions with selected antivirals 2 3

  2014cites this paper
• Liquid oral suspension adefovir dipivoxil (GS-02-526): an update on treatments for hepatitis B infection

  2014cites this paper
• Pharmacogenomics of antimicrobial agents.

  2014cites this paper
• Renal Handling of Amphotericin B and Amphotericin B-Deoxycholate and Potential Renal Drug-Drug Interactions with Selected Antivirals

  2014cites this paper
• Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention

  2014influential citation